These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15625645)

  • 1. Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C.
    Lörke J; Erhardt A; Häussinger D
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):xx. PubMed ID: 15625645
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.
    Cholongitas E; Samonakis D; Patch D; Senzolo M; Burroughs AK; Quaglia A; Dhillon A
    Transplantation; 2006 Feb; 81(3):488-90. PubMed ID: 16477242
    [No Abstract]   [Full Text] [Related]  

  • 3. De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.
    Tovar JL; Buti M; Segarra A; Majó J; Esteban R
    Int Urol Nephrol; 2008; 40(2):539-41. PubMed ID: 17987400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity.
    Yasui S; Fujiwara K; Yokosuka O
    Dig Liver Dis; 2011 Aug; 43(8):666-7. PubMed ID: 21435960
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autoimmune hepatitis and membranous glomerulonephritis under immune therapy in chronic hepatitis C].
    Paparoupa M; Huy Ho NA; Schuppert F
    Dtsch Med Wochenschr; 2016 May; 141(10):709-11. PubMed ID: 27176065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.
    Kogure T; Ueno Y; Fukushima K; Nagasaki F; Inoue J; Kakazu E; Matsuda Y; Kido O; Nakagome Y; Kimura O; Obara N; Wakui Y; Iwasaki T; Shimosegawa T
    World J Gastroenterol; 2007 Aug; 13(32):4394-7. PubMed ID: 17708618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
    Callens S; Bottieau E; Michielsen P; Colebunders R
    AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C.
    Thomas WL; Ramos F; Hospenthal DR
    Hawaii Med J; 2003 Aug; 62(8):163-4. PubMed ID: 14533347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe streptococcal cellulitis after subcutaneous pegylated interferon alfa-2B in a diabetic patient.
    Lanternier F; Bon C; Memain N; Roulot D; Lortholary O
    Gastroenterol Clin Biol; 2004 Dec; 28(12):1294-5. PubMed ID: 15671943
    [No Abstract]   [Full Text] [Related]  

  • 10. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
    Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
    Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature.
    Adla M; Downey KK; Ahmad J
    Dig Dis Sci; 2008 Oct; 53(10):2810-2. PubMed ID: 18320314
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.
    Kraus MR; Schäfer A; Csef H; Scheurlen M
    World J Gastroenterol; 2005 Mar; 11(12):1769-74. PubMed ID: 15793861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.
    Coriat R; Podevin P
    Int J STD AIDS; 2008 Mar; 19(3):208-10. PubMed ID: 18397566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence.
    Lodato F; Tame MR; Colecchia A; Racchini C; Azzaroli F; D'Errico A; Casanova S; Pinna A; Roda E; Mazzella G
    World J Gastroenterol; 2006 Jul; 12(26):4253-5. PubMed ID: 16830387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
    de Lédinghen V; Trimoulet P; Winnock M; Foucher J; Bourlière M; Desmorat H; Canva V; Capron D; Lévy S; Mion F; Mannant PR; Chêne G; Fleury H; Couzigou P; Bernard PH;
    J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
    Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Grazi G; Bernardi M; Andreone P
    Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D; Reifenberger J
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C.
    Sood A; Midha V; Sood N
    Indian J Gastroenterol; 2004; 23(1):28-9. PubMed ID: 15106716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anterior uveitis in a patient treated with pegylated interferon and ribavirin].
    Carneros Martín JA; Fuentes Coronel A; Alvarez Delgado A; González San Martín F
    Med Clin (Barc); 2003 Mar; 120(9):359. PubMed ID: 12646118
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.
    Lindsay KL; Trepo C; Heintges T; Shiffman ML; Gordon SC; Hoefs JC; Schiff ER; Goodman ZD; Laughlin M; Yao R; Albrecht JK;
    Hepatology; 2001 Aug; 34(2):395-403. PubMed ID: 11481625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.